Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study

ConclusionsSulphonylurea use was associated with higher risks of incident AF, stroke, cardiovascular mortality and all-cause mortality compared to metformin. Males and patients older than 65  years with sulphonylurea use were exposed to the highest risks.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research